These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7306225)

  • 1. Decreased capacity to solubilize immune complexes in sera from patients with systemic lupus erythematosus.
    Aguado MT; Perrin LH; Miescher PA; Lambert PH
    Arthritis Rheum; 1981 Oct; 24(10):1225-9. PubMed ID: 7306225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune deposits in normal skin of patients with systemic lupus erythematosus: relationship to the serum capacity to solubilize immune complexes.
    Gabrielli A; Corvetta A; Montroni M; Rupoli S; Danieli G
    Clin Immunol Immunopathol; 1985 Sep; 36(3):266-74. PubMed ID: 4017290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera.
    Balestrieri G; Pagani D; Tincani A
    J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of immune complex solubilization: complement function in relation to disease activity in SLE.
    Sturfelt G; Nived O; Sjöholm AG
    Clin Exp Rheumatol; 1992; 10(3):241-7. PubMed ID: 1582069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of factor D concentrations on fluid phase C3 activation, lysis of rabbit erythrocytes and solubilization of immune complexes.
    Sturfelt G; Sjöholm AG; Truedsson L
    Immunol Lett; 1989 Feb; 20(3):231-6. PubMed ID: 2714846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
    Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
    Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Solubility of immune complexes and activity of the alternative complement pathway in patients with systemic lupus erythematosus].
    Riera Cervantes N; Geffner J; Isturiz MA; Manni JA; de Bracco MM
    Rev Clin Esp; 1985 Oct; 177(6):254-7. PubMed ID: 4081196
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capacity to solubilize immune complexes in sera and synovial fluids from patients with rheumatoid arthritis.
    Dayer E; Gerster JC; Aguado MT; Lambert PH
    Arthritis Rheum; 1983 Feb; 26(2):156-64. PubMed ID: 6824512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated solubilization of immune complexes. Solubilization inhibition and complement factor levels in SLE patients.
    Baatrup G; Petersen I; Kappelgaard E; Jepsen HH; Svehag SE
    Clin Exp Immunol; 1984 Feb; 55(2):313-8. PubMed ID: 6230182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis.
    Sølling J; Sølling K; Jacobsen KU
    Acta Derm Venereol; 1979; 59(5):421-6. PubMed ID: 93365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus.
    Abramson SB; Given WP; Edelson HS; Weissmann G
    Arthritis Rheum; 1983 May; 26(5):630-6. PubMed ID: 6847725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple enzyme immunoassay for measurement of immune complex solubilization utilizing preformed peroxidase-antiperoxidase complexes.
    Johansson I; Sturfelt G; Truedsson L
    J Immunoassay; 1994 Nov; 15(4):393-409. PubMed ID: 7836544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.
    Bányai A; Szabó G; Csongor J; Sonkoly I; Szegedi G
    Acta Med Hung; 1985; 42(1-2):51-7. PubMed ID: 4034337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of beta 1H globulin together with C3 in the dermal-epidermal junction of patients with systemic lupus erythematosus.
    Carlo JR; Rothfield NF; Ruddy S
    Arthritis Rheum; 1979 Jan; 22(1):13-8. PubMed ID: 83148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement behavior in infectious mononucleosis: possible mechanisms for the prevention of immune complex injury.
    Charlesworth JA; Endre ZH; Pussell BA; Yasmeen D; Peake PW
    J Infect Dis; 1982 Apr; 145(4):505-13. PubMed ID: 7069231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of plasma-exchange on complement-mediated solubilization of circulating immune complexes in patients with systemic lupus erythematosus.
    Schena FP; Pastore A; Manno C; Varvara B
    Int J Artif Organs; 1985 Jul; 8 Suppl 2():3-6. PubMed ID: 4055109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.